Cutaneous leishmaniasis (CL) is the most common form of leishmaniasis, being endemic in more than 90 countries around the world. The increasing number of international travelers to endemic areas has favored the expanding number of imported cases, making CL a mayor health issue.1,2 Herein, we report three immunocompetent children with multifocal CL caused by Leishmania tropica who received systemic therapy with liposomal amphotericin B (L-AmB).
This article is protected by copyright. All rights reserved.
http://ift.tt/2sW1OhN
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου